An interventional study of Brief Behavioral Activation Intervention in Depression, Asthma and Urticaria, sponsored by University of Mississippi Medical Center. Terminated at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2018-04-19.
Sponsored by University of Mississippi Medical Center · Not applicable, Interventional, and Treatment
Depression and other unhealthy behaviors, such as not taking medication as prescribed and not attending doctor visits have been suggested to increase the worsening of allergic diseases (e.g. asthma, urticaria). We intend to determine whether a one-session behavioral intervention is effective in helping with depression and controlling disease symptoms. We will measure this using pre- and post-intervention surveys.
The purpose of this research study is to investigate whether a one-session behavioral activation intervention for depression can successfully reduce depression and improve asthma or urticaria disease-relevant outcomes (medication adherence, doctor's visits, substance abuse) in clinical patients with asthma or urticaria who report heightened levels of depression and are seen in the UMMC Allergy Clinic.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's enrollment of 18 is below the median of 83 across 2,752 interventional studies indexed under Asthma.
Browse Asthma studies →University of Mississippi Medical Center is the lead sponsor of 125 studies on the registry; 19 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 4 (57%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
All eligible participants will undergo the Brief Behavioral Activation Intervention.
Behavioral: Brief Behavioral Activation Intervention
Clinical psychologists (investigators) will instruct the participant in ways to become more active in life, particularly with regards to activities that the participant finds pleasurable and meaningful. The intervention will take one hour to complete. Following the intervention, the participant will receive brief, weekly text or email reminders for the next 4 weeks (total of 4) to engage in pleasurable and meaningful activities during the week.
Asthma Control Test
Changes in asthma control over a 4 week period.
Time frame: 4 weeks
Urticaria Control Test
Changes in urticaria control over a 4 week period.
Time frame: 4 weeks
Asthma Quality of Life Questionnaire
Changes in asthma quality of life over a 4 week period.
Time frame: 4 weeks
Urticaria Activity Score Questionnaire
Changes in the activity of urticaria over a 4 week period.
Time frame: 4 weeks
Psychological Measures (Composite)
Effects of brief behavioral activation intervention based upon psychological differences including depression and anxiety measured over a 4 week period.
Time frame: 4 weeks
Immune biomarkers
Changes in Regulatory T (Treg), Type 1 Regulatory (Tr1), T helper (TH3), T helper 1 (TH1), T helper 2 (TH2), cells, Interferon gamma (IFNg), Interleukin 4 (IL4) and Interleukin 10 (IL10) cytokine production from baseline to 4 weeks.
Time frame: 4 weeks
This study is terminated, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Mississippi Medical Center